AXL and neoplasm: More importantly, aberrant glycosylation of AXL was reported to contribute to tumor proliferation, invasion and metastasis [42], and alpha-2, 6-sialyltransferases ST6GalNAcII was further identified as critical modulator of its functions in mammary phyllodes tumors [43].